Skip to main content

Opioid Trial In Georgia Delayed

Opioid Trial In Georgia Delayed

Opioid Trial In Georgia Delayed

Introduction

An opioid trial in Georgia state court against drug distributors brought by the families affected by opioid addiction has been delayed due to a lawyer conflict.

Most of the opioid trials against the companies allege that the public nuisance of the companies' opioid activities caused the opioid crisis, which has harmed communities. But the current trial stands out as it is brought against the company by 21 private plaintiffs who are mostly minors.

The complaint states that the companies were aware of the huge amount of opioids being distributed in the county for profits from the illegal drug market. The defendant companies in the lawsuit are Cardinal Health, McKesson, pharmacies and other related groups. The plaintiffs include children, spouses, siblings and parents of opioid-addicted people along with people seeking compensation due to opioid harm. The dealers of illegal drugs are held responsible in the suit under the Georgia Drug Dealer Liability Act.

The plaintiffs' attorney said that it is the first case of such kind that falls under the drug dealer law. The attorney even stated that it is uncertain to tell when the trial might start.

The trial of the suit was slated to start on March 21 but has got postponed. Another opioid trial by the state of Rhode Island ended in a $100 million settlement to be paid by the drug distributors and manufacturers.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!